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In-host pathogen evolution influences disease progression and chronicity, but forces that shape this remain
poorly understood. In this issue ofCell Host &Microbe, Jorth et al. (2015) describe regional subpopulations of
Pseudomonas aeruginosa in lungs from cyctic fibrosis patients and provide support for compartmentaliza-
tion-driven evolution of this bacterium.Phenotypic and genotypic heterogeneity
of pathogens influence disease progres-
sion and pose a primary challenge to
treating and overcoming bacterial infec-
tions. Genetic diversification during infec-
tions can enhance the pathogenic poten-
tial of bacterial populations by enabling
rapid adaptation to host conditions in-
cluding nutrients, immune response, and
drug treatment. The emergence of patho-
adaptive mutations is of particular impor-
tance during chronic infections, in which
pathogens persist in the human body for
months, years, or even decades (Sokur-
enko et al., 1999). A well-known example
are mutations leading to the overproduc-
tion of alginate, a cell-surface exopoly-
saccharide that dramatically increases
the resistance of Pseudomonas aerugi-
nosa isolates to pulmonary clearance
mechanisms in lungs of cystic fibrosis
(CF) patients (Folkesson et al., 2012). In
agreement with this idea, a breakthrough
genomic study in 2006 for the first time
outlined how P. aeruginosa evolves within
CF lungs during infection (Smith et al.,
2006).
P. aeruginosa is a ubiquitous Gram-
negative bacterium capable of thriving in
a large repertoire of habitats including
different immunocompromised human or-
gans and is a major cause of mortality
associated with CF (Cripps et al., 1995).
Chronic infections of CF lungs by
P. aeruginosa are difficult to eradicate
and are particularly prone to select for
drug-resistant variants. Airways of CF
patients are colonized during early child-
hood and remain chronically infected
by the descendants of the same clone.
However, isolates from chronically in-
fected CF patients are often remarkably
different from the isolates that initiated268 Cell Host & Microbe 18, September 9, 20the infections years before. Significant
phenotypic diversity (colony morphology,
regulatory features, or drug-resistance
profiles) is observed within P. aeruginosa
populations sampled from the same pa-
tient with variations often being acceler-
ated by mutators, strains with greatly
increased mutation rates (Clark et al.,
2015; Oliver et al., 2000; Williams et al.,
2015).
Recent studies focusing on longitu-
dinal long-term sampling of patient
cohorts describe microevolution of
P. aeruginosa in the host. This revealed
extensive phenotypic and genotypic di-
versity among P. aeruginosa isolates and
showed distinct sub-clonal lineages to
co-exist in individual patients with CF
(e.g., Marvig et al., 2015). However, the
forces that drive bacterial diversification
and how this affects the pathogenic po-
tential of specific isolates remains un-
clear. Also, it is not clear if stable subpop-
ulations evolve in isolated regions of the
human airways, possibly in response to
specific selective pressure or as a result
of genetic drift. CF airways are highly
structured environments that differ re-
gionally in oxygen and carbon dioxide
tension, drug concentration, or the degree
of inflammation and tissue damage. A
better understanding of population dy-
namics and infection progression thus
requires an appreciation of how spatially
structured subpopulations evolve and
interact within the CF lung tissue. Markus-
sen et al. (2014) recently reported that
intraclonal population diversity arises
immediately after initial colonization re-
sulting in the co-existence of distinct
and stable sublineages. Importantly, this
study proposed that population diversity
arises from partitioning into physically15 ª2015 Elsevier Inc.separated compartments of patients’
airways.
In this issue, Jorth et al. (2015) extend
our understanding of spatial separation
and microbial population dynamics in CF
lungs considerably. While earlier studies
relied primarily on sampling from patient
sputum, thereby blurring regional pop-
ulation differences, Jorth et al. (2015)
sectioned ten explanted lung pairs col-
lecting a total of 12,000 P. aeruginosa
isolates from the organ’s upper, middle,
and lower lobes. Phenotypic profiling,
proteome analysis, and whole-genome
sequencing revealed strong regional dif-
ferences in all lungs, implying indepen-
dent evolution of certain traits in each
region. For example, in one patient, a
large fraction of ciprofloxacin-resistant
P. aeruginosa was isolated from the left
upper lobe, while all isolates from the
lower lobe were susceptible. Likewise,
isolates from the upper, more damaged
lobe of one of the lungs examined ex-
hibited higher cytotoxicity, virulence, and
neutrophil resistance and triggered a
stronger immune response. This behavior
correlated with the prevalence of a SNP in
exsD, encoding a negative regulator of the
type 3 secretion (T3S) system, one of the
most potent bacterial virulence factors.
This finding is surprising because T3S
systems and other virulence factors are
often found inactivated at relatively early
stages of lung infections (Smith et al.,
2006). Thus, it is possible that the spatial
resolution provided by this study reveals
specific local resurgence of virulence
traits at very late stages of infection.
Based on these findings, Jorth et al.
(2015) propose that compartmentali-
zation—independent evolution due to
spatial separation—is one of the drivers
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corroborate this idea, the authors
sequenced 288 isolates from different
lung regions of individual patients. Phy-
logenies of strains strongly clustered
according to their region of isolation, indi-
cating limited mixing of bacterial popula-
tions. While phenotypic profiling had
shown that multiple distinct subpopula-
tions co-exist throughout the lung, geno-
typing revealed that only one or few subli-
neages dominated each specific region
examined. A key factor for spatially inde-
pendent evolution could be limited traf-
ficking of bacteria between different
zones of the lung. This could be due to
loss of motility or physical separation by
factors such as thick mucus in the CF air-
ways. Alternatively, one cannot exclude
interactions between different popula-
tions being involved in the observed
segregation.
The important question of whether
regional differences in P. aeruginosa evo-
lution result from specific selection or
from random drift remains. Evidence for
convergent evolution of P. aeruginosa
was recently obtained in young individ-
uals with cystic fibrosis (Marvig et al.,
2015), arguing that infecting populations
may adapt to the selection pressure of
specific niches in the lung. Unfortunately,
the study by Jorth et al. (2015) is vague
regarding this question. While there is
no correlation of single phenotypes or
genomic and proteomic signatures asso-
ciated with a specific lung region, Monte
Carlo simulations revealed that the topo-
logic distribution of phenotypic patterns
among the ten patients is ‘‘non-random.’’
This suggests that local selection re-gimes may differentially shape the evolu-
tion of sub-clonal lineages. However, the
absence of clear regional patterns of
single phenotypesmay also hint at patient
variability or stochastic effects. Possibly,
regional evolution might result from a
combination of selection and drift.
Jorth et al. (2015) offer one of the
most comprehensive studies thus far
for the characterization of a pathogen’s
adaptation to human hosts. Using a com-
bination of clever sampling approach with
comprehensive phenotypic and genome
analyses, they provide solid evidence in
favor of limited pathogen migration and
regional pathogen diversification in CF
lungs. These findings have important con-
sequences, as they suggest that path-
ogen populations are genetically complex
and that individual isolates, their pheno-
types, and drug resistance profiles might
be poor predictors for the pathogenic
potential and for therapeutic interven-
tion strategies in infected patients. More-
over, geographic isolation of pathogen
lineages might allow different evolu-
tionary answers to similar environmental
constraints to co-exist without undergo-
ing direct competition. For example,
strains exhibiting antibiotic resistance
could be maintained despite elevated
fitness costs. It will now be important to
explore how predictable evolution is in
different subregions of the lung, to which
extent disease progression influences
pathogen evolution, and how these ge-
netic changes feed-back on the disease.
For this, more in-depth studies are
required. While deep sequencing will be
a very powerful method, sampling meth-
odology will be one of the limiting factorsCell Host & Microbe 18, Sin order to further improve spatial resolu-
tion and correlate phenotypes with the
underlying anatomy and pathology.
Importantly, to provide the necessary
blueprint for the deciphering of the
genomic information obtained in vivo, a
better molecular understanding of micro-
bial cells and their specific interactions
with the host will be imperative.
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